Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2025-12-28 @ 4:21 PM
Study NCT ID:
NCT06850766
Status:
RECRUITING
Last Update Posted:
2025-11-28
First Post:
2025-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
Sponsor:
Ottawa Hospital Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-05
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-05
First Submit QC Date:
None
Study First Post Date:
2025-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-21
Last Update Post Date:
2025-11-28
Last Update Post Date Type:
ESTIMATED